Search

everythinglearnresearchcommunity

for

Search:↓

Long-term use of dutasteride for enlarged prostate may worsen blood sugar, cholesterol, and erectile dysfunction.

The French Endocrine Society suggests diagnosing PCOS with two of three signs, recommends lifestyle changes and clomiphene for treatment, and calls for more research on certain treatments and tests.

Women with PCOS have a higher risk of metabolic syndrome and need lifestyle changes and treatment.

Mild thyroid issues don't affect the metabolism and hormones of women with PCOS.

Young Czech women with PCOS have a higher risk of heart problems and should be regularly checked for cholesterol and glucose issues.

Skin problems in patients with polycystic ovarian disease are linked to body weight, blood sugar, and hormone levels.

IL6 is linked to higher risk of heart disease in people with a certain mouth condition.

New hair growth corticosterone levels are higher in diabetic mice, indicating long-term stress.

The document concludes that proper diagnosis and tailored long-term treatment can effectively manage androgenic disorders in women, improving patient care outcomes.

Exercise is crucial for managing polycystic ovary syndrome (PCOS) and improving overall health.

Female mice with disrupted 5α-reductase 1 had significant metabolic issues, including stress response problems, insulin resistance, liver fat buildup, and obesity.

Rosuvastatin improves lipid levels, reduces inflammation, but worsens insulin sensitivity in men with early-onset hair loss.

The woman's high testosterone levels indicated PCOS, leading to treatment that improved her symptoms.

Vitamin D deficiency is common in women with PCOS and linked to some metabolic problems, but not the main cause of their metabolic issues.

Androgen is important in controlling stem cell differentiation, reducing fat development, and increasing lean mass.

The document concludes that early recognition and treatment of PCOS in adolescents is crucial for managing symptoms and long-term health risks.

Insulin resistance might not be enough to worsen blood vessel function in young, nonobese women with polycystic ovary syndrome.

Metformin and rosiglitazone both improved insulin use and hormonal symptoms in women with PCOS.

Hair analysis showed very high metformin levels in two fatal overdose cases, suggesting it's useful in forensics but sweat may affect results.

Lower vaspin levels in the blood may indicate a better response to fertility treatment in women with PCOS.

Women with PCOS have lower amylin levels, which are not related to their body weight.

Lower hair copper and copper-to-zinc ratio are linked to more severe coronary artery disease.

Women with acromegaly often have irregular periods due to hormone imbalances and growth hormone effects.

Women with PCOS have higher xanthine oxidase activity linked to inflammation and heart disease risks.

Men with Type 2 Diabetes have lower DHT levels, which may affect fertility and lipid profiles.

Women with PCOS are more likely to have fatty liver disease and worse metabolic health.

Metformin may help regulate periods and cause modest weight loss in PCOS patients, but more research is needed.

A pregnant woman's skin condition improved after giving birth, possibly due to high estrogen levels during pregnancy.

High levels of male hormones and irregular periods best predict how well PCOS patients will respond to metformin treatment.

Women with PCOS often have sleep problems, including sleep apnea, which are linked to obesity and depression.